Czech National Bank’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.2M | Buy |
143,385
+7,917
| +6% | +$619K | 0.09% | 205 |
|
2025
Q1 | $9.82M | Buy |
135,468
+7,587
| +6% | +$550K | 0.09% | 215 |
|
2024
Q4 | $9.47M | Buy |
127,881
+5,166
| +4% | +$382K | 0.09% | 205 |
|
2024
Q3 | $8.1M | Buy |
122,715
+7,883
| +7% | +$520K | 0.08% | 230 |
|
2024
Q2 | $10.6M | Buy |
114,832
+8,118
| +8% | +$750K | 0.12% | 159 |
|
2024
Q1 | $10.2M | Buy |
106,714
+489
| +0.5% | +$46.7K | 0.13% | 157 |
|
2023
Q4 | $8.1M | Sell |
106,225
-27
| -0% | -$2.06K | 0.12% | 177 |
|
2023
Q3 | $7.36M | Buy |
106,252
+34,487
| +48% | +$2.39M | 0.12% | 171 |
|
2023
Q2 | $6.77M | Sell |
71,765
-1,070
| -1% | -$101K | 0.15% | 134 |
|
2023
Q1 | $6.03M | Buy |
72,835
+462
| +0.6% | +$38.2K | 0.15% | 137 |
|
2022
Q4 | $5.4M | Buy |
72,373
+327
| +0.5% | +$24.4K | 0.14% | 155 |
|
2022
Q3 | $5.95M | Buy |
+72,046
| New | +$5.95M | 0.17% | 127 |
|